Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis.

Drug Des Devel Ther

Drug Metabolism and Pharmacokinetics, Johns Hopkins Drug Discovery Program, Johns Hopkins University.

Published: July 2018

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404796	PMC
http://dx.doi.org/10.2147/DDDT.S137116	DOI Listing

Publication Analysis

pharmacokinetic interactions

interactions glimepiride

glimepiride rosuvastatin

rosuvastatin healthy

healthy korean

korean subjects

subjects slco1b1

slco1b1 cyp2c9

cyp2c9 genetic

genetic polymorphism

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!